» Articles » PMID: 33996741

ApoE and ApoE Nascent-Like HDL Particles at Model Cellular Membranes: Effect of Protein Isoform and Membrane Composition

Abstract

Apolipoprotein E (ApoE), an important mediator of lipid transportation in plasma and the nervous system, plays a large role in diseases such as atherosclerosis and Alzheimer's. The major allele variants ApoE3 and ApoE4 differ only by one amino acid. However, this difference has major consequences for the physiological behaviour of each variant. In this paper, we follow (i) the initial interaction of lipid-free ApoE variants with model membranes as a function of lipid saturation, (ii) the formation of reconstituted High-Density Lipoprotein-like particles (rHDL) and their structural characterisation, and (iii) the rHDL ability to exchange lipids with model membranes made of saturated lipids in the presence and absence of cholesterol [1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) or 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC) with and without 20 mol% cholesterol]. Our neutron reflection results demonstrate that the protein variants interact differently with the model membranes, adopting different protein conformations. Moreover, the ApoE3 structure at the model membrane is sensitive to the level of lipid unsaturation. Small-angle neutron scattering shows that the ApoE containing lipid particles form elliptical disc-like structures, similar in shape but larger than nascent or discoidal HDL based on Apolipoprotein A1 (ApoA1). Neutron reflection shows that ApoE-rHDL do not remove cholesterol but rather exchange saturated lipids, as occurs in the brain. In contrast, ApoA1-containing particles remove and exchange lipids to a greater extent as occurs elsewhere in the body.

Citing Articles

Performance of nanoparticles for biomedical applications: The / discrepancy.

Berger S, Berger M, Bantz C, Maskos M, Wagner E Biophys Rev (Melville). 2024; 3(1):011303.

PMID: 38505225 PMC: 10903387. DOI: 10.1063/5.0073494.


Expanding the Toolbox for Bicelle-Forming Surfactant-Lipid Mixtures.

Del Giudice R, Paracini N, Laursen T, Blanchet C, Roosen-Runge F, Cardenas M Molecules. 2022; 27(21).

PMID: 36364455 PMC: 9658636. DOI: 10.3390/molecules27217628.

References
1.
Gogonea V . Structural Insights into High Density Lipoprotein: Old Models and New Facts. Front Pharmacol. 2016; 6:318. PMC: 4709926. DOI: 10.3389/fphar.2015.00318. View

2.
Bayburt T, Sligar S . Membrane protein assembly into Nanodiscs. FEBS Lett. 2009; 584(9):1721-7. PMC: 4758813. DOI: 10.1016/j.febslet.2009.10.024. View

3.
Jones M, Zhang L, Catte A, Li L, Oda M, Ren G . Assessment of the validity of the double superhelix model for reconstituted high density lipoproteins: a combined computational-experimental approach. J Biol Chem. 2010; 285(52):41161-71. PMC: 3003414. DOI: 10.1074/jbc.M110.187799. View

4.
Skar-Gislinge N, Simonsen J, Mortensen K, Feidenhansl R, Sligar S, Moller B . Elliptical structure of phospholipid bilayer nanodiscs encapsulated by scaffold proteins: casting the roles of the lipids and the protein. J Am Chem Soc. 2010; 132(39):13713-22. PMC: 4120756. DOI: 10.1021/ja1030613. View

5.
Valanti E, Dalakoura-Karagkouni K, Sanoudou D . Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis. J Pers Med. 2018; 8(4). PMC: 6313318. DOI: 10.3390/jpm8040034. View